Zobrazeno 1 - 2
of 2
pro vyhledávání: '"aldehydoxidasa"'
Autor:
Vavrová, Katarína
Lenvatinib is an oral anticancer drug that belongs to a group of tyrosine kinases, which block signal pathway receptors for development and proliferation of various cancer diseases. Lenvatinib was approved in 2015 for a treatment of progressive, loca
Externí odkaz:
http://www.nusl.cz/ntk/nusl-379364
Autor:
Vavrová, Katarína
Lenvatinib is an oral anticancer drug that belongs to a group of tyrosine kinases, which block signal pathway receptors for development and proliferation of various cancer diseases. Lenvatinib was approved in 2015 for a treatment of progressive, loca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::652a58d4929c442dc398f1cb6e51de9a
http://www.nusl.cz/ntk/nusl-379364
http://www.nusl.cz/ntk/nusl-379364